{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:44:35Z","timestamp":1648885475410},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T00:00:00Z","timestamp":1335312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00059-012-3612-2","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T09:38:05Z","timestamp":1335346685000},"page":"311-320","source":"Crossref","is-referenced-by-count":0,"title":["Besonderheiten der Infarkttherapie bei Diabetes"],"prefix":"10.1007","volume":"37","author":[{"given":"W.","family":"Motz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,25]]},"reference":[{"key":"3612_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T et al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229\u2013234","journal-title":"N Engl J Med"},{"key":"3612_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2796.2001.00789.x","volume":"249","author":"Laasko","year":"2001","unstructured":"Laasko M (2001) Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 249:225\u2013235","journal-title":"J Intern Med"},{"key":"3612_CR3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0195-668X(02)00828-X","volume":"24","author":"Norhammar","year":"2003","unstructured":"Norhammar A, Malmberg K, Ryden L et al (2003) Under utilisation of evidence-based treatment partially explains the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 24:838\u2013844","journal-title":"Eur Heart J"},{"key":"3612_CR4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ahj.2005.08.006","volume":"151","author":"Roe","year":"2006","unstructured":"Roe MT, Peterson ED, Newby LK et al (2006) The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 151:1205\u20131213","journal-title":"Am Heart J"},{"key":"3612_CR5","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","volume":"29","author":"Van","year":"2008","unstructured":"Van de Werf F, Bax J, Betriu A et al; ESC Committee for Practice Guidelines (CPG) (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909\u20132945","journal-title":"Eur Heart J"},{"key":"3612_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12181-011-0375-6","volume":"5","author":"Scheller","year":"2011","unstructured":"Scheller B, Levenson B, Joner M et al (2011) Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter. Kardiologe 5:411\u2013435","journal-title":"Kardiologe"},{"key":"3612_CR7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","volume":"16","author":"Stamler","year":"1993","unstructured":"Stamler J, Vaccaro O, Neaton JD et al (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Internvention Trial. Diabetes Care 16:434\u201344","journal-title":"Diabetes Care"},{"key":"3612_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3132\/dvdr.2005.001","volume":"2","author":"Stratmann","year":"2005","unstructured":"Stratmann B, Tschoepe D (2005) Pathobiology and cell interactions of platelets in diabetes. Diab Vasc Dis Res 2:16\u201323","journal-title":"Diab Vasc Dis Res"},{"key":"3612_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2337\/dc08-s257","volume":"31","author":"Stirban","year":"2008","unstructured":"Stirban AO, Schoepe D (2008) Cardiovascular complications in diabetes: targets and interventions. Diabetes Care 31(Suppl 2):215\u2013221","journal-title":"Diabetes Care"},{"key":"3612_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12181-008-0116-7","volume":"2","author":"Breuckmann","year":"2008","unstructured":"Breuckmann F, Post F, Giannitsis E et al (2008) Kriterien der Deutschen Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung f\u00fcr \u201eChest-Pain-Units\u201c. Kardiologe 2:389\u2013394","journal-title":"Kardiologe"},{"key":"3612_CR11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12181-009-0246-6","volume":"4","author":"Silber","year":"2010","unstructured":"Silber S, Borggrefe M, Hasenfu\u00df G, Falk V (2010) Kommentare zu den Leitlinien der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie (ESC) zur Diagnostik und Therapie von Patienten mit ST-Streckenhebungsinfarkt (STEMI). Kardiologe 4(2):84\u201392","journal-title":"Kardiologe"},{"key":"3612_CR12","doi-asserted-by":"crossref","first-page":"a1331","DOI":"10.1136\/bmj.a1331","volume":"337","author":"Stettler","year":"2008","unstructured":"Stettler C, Allemann S, Wandel S et al (2008) Drug eluting and bare metal stents in people with and without diabetes: collaborative network metaanalysis. BMJ 337:a1331","journal-title":"BMJ"},{"key":"3612_CR13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jacc.2007.07.035","volume":"50","author":"Baumgart","year":"2007","unstructured":"Baumgart D, Klauss V, Baer F et al (2007) One-year results of the SCORPIUS study: a German multicenter investigation of the effectiveness of sirolimus-eluting stents in diabetic patients. J Am Coll Cardiol 50:1627\u20131634","journal-title":"J Am Coll Cardiol"},{"key":"3612_CR14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2009.09.057","volume":"55","author":"Banning","year":"2010","unstructured":"Banning AP, Westaby S, Morice MC et al (2010) Diabetic and nondiabetic patients with left main and\/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 55:1067\u20131075","journal-title":"J Am Coll Cardiol"},{"key":"3612_CR15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00392-008-0703-4","volume":"97","author":"Silber","year":"2008","unstructured":"Silber S, Borggrefe M, Bohm M et al (2008) Drug-eluting coronary stents and drug eluting balloon catheters. Summary of the position papers of the DGK. Clin Res Cardiol 97:548\u2013563","journal-title":"Clin Res Cardiol"},{"key":"3612_CR16","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"3612_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","volume":"373","author":"Montalescot","year":"2009","unstructured":"Montalescot G, Wiviott SD, Braunwald E et al (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomized controlled trial. Lancet 373:723\u2013731","journal-title":"Lancet"},{"key":"3612_CR18","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","unstructured":"Hamm W, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999\u20133054","journal-title":"Eur Heart J"},{"key":"3612_CR19","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehi337","volume":"26","author":"Collet","year":"2005","unstructured":"Collet JP, Montalescot G, Agnelli G et al (2005) Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb\/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. Eur Heart J 26:2285\u20132293","journal-title":"Eur Heart J"},{"key":"3612_CR20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-147-5-200709040-00005","volume":"147","author":"Fox","year":"2007","unstructured":"Fox KA, Bassand JP, Mehta SR et al (2007) Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med 147:304\u2013310","journal-title":"Ann Intern Med"},{"key":"3612_CR21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9149(62)90035-8","volume":"9","author":"Sodi-Pallares","year":"1962","unstructured":"Sodi-Pallares D, Testelli MR et al (1962) Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 9:166\u2013181","journal-title":"Am J Cardiol"},{"key":"3612_CR22","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1136\/hrt.2010.194563","volume":"96","author":"Zhao","year":"2010","unstructured":"Zhao YT, Weng CL, Chen ML (2010) Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials. Heart 96(20):1622\u20131626","journal-title":"Heart"},{"key":"3612_CR23","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.CIR.96.4.1152","volume":"96","author":"Fath-Ordoubadi","year":"1997","unstructured":"Fath-Ordoubadi F, Beatt KJ (1997) Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96(4):1152\u20131156","journal-title":"Circulation"},{"key":"3612_CR24","first-page":"e20","volume":"15","author":"Mamas","year":"2010","unstructured":"Mamas MA, Neyses L, Fath-Ordoubadi F (2010) A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction. Exp Clin Cardiol 15(2):e20\u2013e24","journal-title":"Exp Clin Cardiol"},{"key":"3612_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","volume":"26","author":"Malmberg","year":"1995","unstructured":"Malmberg K, Ryden L et al (1995) Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26(1):57\u201365","journal-title":"J Am Coll Cardiol"},{"key":"3612_CR26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.29.04.06.dc05-1894","volume":"29","author":"Cheung","year":"2006","unstructured":"Cheung NW, Wong VW, McLean M (2006) The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29(4):765\u2013770","journal-title":"Diabetes Care"},{"key":"3612_CR27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/ehm124","volume":"28","author":"Ryden","year":"2007","unstructured":"Ryden L, Standl E, Bartnik M et al (2007) Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J 28:88\u2013136","journal-title":"Eur Heart J"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3612-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-012-3612-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-012-3612-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T15:56:34Z","timestamp":1558540594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-012-3612-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,25]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["3612"],"URL":"https:\/\/doi.org\/10.1007\/s00059-012-3612-2","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,25]]}}}